| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.587 | 0.011 | 0.587 | Caspase 3 stimulant | 0.48 0.023 CID_13878 | ||
| 0.449 | 0.004 | 0.449 | Phosphodiesterase 4A inhibitor | 0.352 0.004 CID_13878 | ||
| 0.424 | 0.005 | 0.424 | Aldehyde dehydrogenase inhibitor | 0.314 0.01 CID_13878 | ||
| 0.444 | 0.03 | 0.49 | Aryl hydrocarbon receptor agonist | 0.49 0.025 CID_13878 | CID_13878 | |
| 0.439 | 0.057 | 0.439 | 5 Hydroxytryptamine release inhibitor | 0.418 0.067 CID_13878 | ||
| 0.43 | 0.049 | 0.43 | GABA C receptor rho-3 antagonist | 0.385 0.068 CID_13878 | ||
| 0.373 | 0.004 | 0.374 | Carbonic anhydrase VI inhibitor | 0.374 0.004 CID_13878 | CID_13878 | |
| 0.445 | 0.08 | 0.445 | MAP kinase 1 inhibitor | 0.402 0.105 CID_13878 | ||
| 0.384 | 0.025 | 0.384 | Psychostimulant | 0.311 0.04 CID_13878 | ||
| 0.352 | 0.004 | 0.388 | AXL receptor tyrosine kinase inhibitor | 0.388 0.004 CID_13878 | CID_13878 | |
| 0.339 | 0.003 | 0.339 | Transcription factor AP-1 inhibitor | 0.247 0.004 CID_13878 | ||
| 0.411 | 0.091 | 0.411 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.32 0.187 CID_13878 | ||
| 0.319 | 0.005 | 0.319 | Carbonic anhydrase XIII inhibitor | 0.26 0.008 CID_13878 | ||
| 0.335 | 0.026 | 0.415 | RNA-directed DNA polymerase inhibitor | 0.415 0.017 CID_13878 | CID_13878 | |
| 0.374 | 0.075 | 0.374 | MAP kinase kinase 6 inhibitor | 0.307 0.129 CID_13878 | ||
| 0.33 | 0.04 | 0.495 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.495 0.013 CID_13878 | CID_13878 | |
| 0.287 | 0.004 | 0.287 | CF transmembrane conductance regulator agonist | 0.245 0.007 CID_13878 | ||
| 0.396 | 0.114 | 0.396 | Caspase 9 stimulant | 0.273 0.225 CID_13878 | ||
| 0.31 | 0.04 | 0.37 | DNA synthesis inhibitor | 0.37 0.026 CID_13878 | CID_13878 | |
| 0.308 | 0.05 | 0.469 | Dyrk kinase inhibitor | 0.469 0.017 CID_13878 | CID_13878 | |
| 0.285 | 0.053 | 0.285 | 5 Hydroxytryptamine uptake stimulant | 0.229 0.105 CID_13878 | ||
| 0.258 | 0.028 | 0.258 | Tumour necrosis factor antagonist | 0.253 0.03 CID_13878 | ||
| 0.251 | 0.023 | 0.251 | Alpha-N-acetylglucosaminidase inhibitor | 0.151 0.055 CID_13878 | ||
| 0.304 | 0.08 | 0.52 | Immunomodulator | 0.52 0.02 CID_13878 | CID_13878 | |
| 0.225 | 0.005 | 0.225 | Cyclin E1 inhibitor | 0.177 0.006 CID_13878 | ||
| 0.261 | 0.045 | 0.303 | Peroxidase inhibitor | 0.303 0.037 CID_13878 | CID_13878 | |
| 0.224 | 0.009 | 0.224 | CXC chemokine 4 receptor antagonist | 0.161 0.014 CID_13878 | ||
| 0.223 | 0.009 | 0.335 | Adenosine A2 receptor antagonist | 0.335 0.005 CID_13878 | CID_13878 | |
| 0.219 | 0.005 | 0.219 | Cyclin E inhibitor | 0.182 0.007 CID_13878 | ||
| 0.222 | 0.009 | 0.331 | Adenosine A2a receptor antagonist | 0.331 0.005 CID_13878 | CID_13878 | |
| 0.237 | 0.025 | 0.338 | Heat shock protein 90 antagonist | 0.338 0.006 CID_13878 | CID_13878 | |
| 0.265 | 0.055 | 0.265 | Tyrosine 3 hydroxylase inhibitor | 0.221 0.101 CID_13878 | ||
| 0.21 | 0.005 | 0.21 | Carbonic anhydrase VB inhibitor | 0.163 0.008 CID_13878 | ||
| 0.211 | 0.006 | 0.211 | Carbonic anhydrase V inhibitor | 0.173 0.01 CID_13878 | ||
| 0.232 | 0.029 | 0.249 | Lck kinase inhibitor | 0.249 0.025 CID_13878 | CID_13878 | |
| 0.337 | 0.136 | 0.337 | Transcription factor inhibitor | |||
| 0.201 | 0.003 | 0.201 | Adenosine A3 receptor agonist | 0.118 0.003 CID_13878 | ||
| 0.199 | 0.002 | 0.199 | Purinergic P2X agonist | 0.151 0.002 CID_13878 | ||
| 0.216 | 0.019 | 0.216 | Ferrochelatase inhibitor | 0.142 0.041 CID_13878 | ||
| 0.2 | 0.003 | 0.2 | Catechol O-methyltransferase inhibitor | 0.159 0.004 CID_13878 | ||
| 0.201 | 0.004 | 0.201 | Carbonic anhydrase XIV inhibitor | 0.14 0.005 CID_13878 | ||
| 0.201 | 0.009 | 0.244 | Adenosine A3 receptor antagonist | 0.244 0.007 CID_13878 | CID_13878 | |
| 0.272 | 0.082 | 0.272 | Hypoxia-inducible factor 1 alpha inhibitor | 0.239 0.111 CID_13878 | ||
| 0.19 | 0.005 | 0.19 | Carbonic anhydrase VA inhibitor | 0.161 0.009 CID_13878 | ||
| 0.196 | 0.011 | 0.28 | Adenosine A1 receptor antagonist | 0.28 0.007 CID_13878 | CID_13878 | |
| 0.207 | 0.023 | 0.227 | Cyclin-dependent kinase 2 inhibitor | 0.227 0.02 CID_13878 | CID_13878 | |
| 0.233 | 0.05 | 0.233 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.209 0.065 CID_13878 | ||
| 0.181 | 0.002 | 0.181 | Prolactin release inhibitor | 0.168 0.002 CID_13878 | ||
| 0.267 | 0.089 | 0.306 | Immunostimulant | 0.306 0.077 CID_13878 | CID_13878 | |
| 0.186 | 0.015 | 0.186 | Telomerase inhibitor | 0.166 0.018 CID_13878 | ||
| 0.225 | 0.055 | 0.231 | Nitric-oxide synthase stimulant | 0.231 0.047 CID_13878 | CID_13878 | |
| 0.193 | 0.024 | 0.227 | Cyclin-dependent kinase 5 inhibitor | 0.227 0.018 CID_13878 | CID_13878 | |
| 0.177 | 0.012 | 0.177 | Carbonic anhydrase inhibitor | 0.125 0.02 CID_13878 | ||
| 0.178 | 0.013 | 0.178 | Aminoacyl-tRNA synthetase inhibitor | 0.175 0.014 CID_13878 | ||
| 0.175 | 0.011 | 0.175 | CDC-like kinase 3 inhibitor | 0.161 0.015 CID_13878 | ||
| 0.209 | 0.048 | 0.209 | 5 Hydroxytryptamine 3E antagonist | 0.181 0.104 CID_13878 | ||
| 0.167 | 0.011 | 0.167 | Carbonic anhydrase IX inhibitor | 0.124 0.015 CID_13878 | ||
| 0.205 | 0.052 | 0.214 | Src kinase inhibitor | 0.214 0.048 CID_13878 | CID_13878 | |
| 0.157 | 0.009 | 0.25 | Interferon agonist | 0.25 0.004 CID_13878 | CID_13878 | |
| 0.277 | 0.13 | 0.294 | Immunosuppressant | 0.294 0.119 CID_13878 | CID_13878 | |
| 0.241 | 0.094 | 0.241 | 5 Hydroxytryptamine release stimulant | 0.182 0.138 CID_13878 | ||
| 0.185 | 0.042 | 0.195 | Cyclin-dependent kinase inhibitor | 0.195 0.039 CID_13878 | CID_13878 | |
| 0.17 | 0.028 | 0.17 | Butyrylcholinesterase inhibitor | 0.093 0.068 CID_13878 | ||
| 0.154 | 0.013 | 0.166 | CDK1/cyclin B inhibitor | 0.166 0.012 CID_13878 | CID_13878 | |
| 0.165 | 0.025 | 0.172 | CDK/cyclin complex inhibitor | 0.172 0.024 CID_13878 | CID_13878 | |
| 0.15 | 0.01 | 0.15 | Carbonic anhydrase II inhibitor | 0.112 0.016 CID_13878 | ||
| 0.149 | 0.013 | 0.149 | Carbonic anhydrase XII inhibitor | 0.104 0.019 CID_13878 | ||
| 0.165 | 0.029 | 0.165 | GABA C receptor agonist | 0.153 0.033 CID_13878 | ||
| 0.146 | 0.01 | 0.146 | Carbonic anhydrase I inhibitor | 0.111 0.016 CID_13878 | ||
| 0.154 | 0.019 | 0.154 | Potassium channel activator | 0.096 0.052 CID_13878 | ||
| 0.177 | 0.045 | 0.177 | GABA C receptor rho-2 antagonist | 0.149 0.075 CID_13878 | ||
| 0.143 | 0.012 | 0.143 | Histamine H2 receptor antagonist | 0.132 0.015 CID_13878 | ||
| 0.133 | 0.003 | 0.133 | Purinergic P2Y2 antagonist | 0.106 0.004 CID_13878 | ||
| 0.256 | 0.128 | 0.256 | Vasodilator, coronary | 0.229 0.155 CID_13878 | ||
| 0.163 | 0.035 | 0.17 | Protein kinase (CK2) alpha inhibitor | 0.17 0.032 CID_13878 | CID_13878 | |
| 0.252 | 0.126 | 0.252 | Transcription factor NF kappa B inhibitor | 0.203 0.166 CID_13878 | ||
| 0.13 | 0.004 | 0.13 | Aggrecanase 1 inhibitor | 0.06 0.009 CID_13878 | ||
| 0.154 | 0.029 | 0.176 | Fibroblast growth factor 1 antagonist | 0.176 0.023 CID_13878 | CID_13878 | |
| 0.132 | 0.009 | 0.132 | Androgen agonist | 0.096 0.016 CID_13878 | ||
| 0.22 | 0.097 | 0.22 | Superoxide dismutase inhibitor | 0.171 0.153 CID_13878 | ||
| 0.14 | 0.019 | 0.161 | Protein kinase B gamma inhibitor | 0.161 0.013 CID_13878 | CID_13878 | |
| 0.145 | 0.028 | 0.166 | CDK2/cyclin A inhibitor | 0.166 0.021 CID_13878 | CID_13878 | |
| 0.149 | 0.033 | 0.149 | Protein kinase (CK2) inhibitor | 0.141 0.037 CID_13878 | ||
| 0.121 | 0.005 | 0.121 | Nicotinic acid receptor 1 agonist | 0.117 0.006 CID_13878 | ||
| 0.196 | 0.082 | 0.237 | DNA methylase inhibitor | 0.237 0.056 CID_13878 | CID_13878 | |
| 0.119 | 0.007 | 0.174 | Interferon inducer | 0.174 0.004 CID_13878 | CID_13878 | |
| 0.203 | 0.092 | 0.203 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.14 | 0.033 | 0.14 | Carbonic anhydrase III inhibitor | 0.108 0.054 CID_13878 | ||
| 0.141 | 0.035 | 0.141 | GABA C receptor antagonist | 0.129 0.044 CID_13878 | ||
| 0.122 | 0.016 | 0.122 | CXC chemokine receptor antagonist | 0.068 0.052 CID_13878 | ||
| 0.113 | 0.009 | 0.18 | Adenosine A2b receptor antagonist | 0.18 0.005 CID_13878 | CID_13878 | |
| 0.123 | 0.023 | 0.123 | MAP kinase 10 inhibitor | 0.086 0.045 CID_13878 | ||
| 0.12 | 0.021 | 0.2 | Purinergic P2X2 antagonist | 0.2 0.005 CID_13878 | CID_13878 | |
| 0.139 | 0.042 | 0.171 | DNA repair enzyme inhibitor | 0.171 0.017 CID_13878 | CID_13878 | |
| 0.205 | 0.111 | 0.205 | DNA damaging | 0.19 0.124 CID_13878 | ||
| 0.126 | 0.032 | 0.156 | Electrolyte absorption antagonist | 0.156 0.017 CID_13878 | CID_13878 | |
| 0.121 | 0.028 | 0.121 | NADH dehydrogenase inhibitor | 0.111 0.034 CID_13878 | ||
| 0.128 | 0.037 | 0.135 | Insulin receptor antagonist | 0.135 0.033 CID_13878 | CID_13878 | |
| 0.097 | 0.009 | 0.178 | Histamine agonist | 0.178 0.004 CID_13878 | CID_13878 | |
| 0.119 | 0.033 | 0.119 | Potassium channel (Voltage-sensitive) activator | 0.089 0.069 CID_13878 | ||
| 0.116 | 0.031 | 0.127 | Platelet growth factor antagonist | 0.127 0.026 CID_13878 | CID_13878 | |
| 0.13 | 0.045 | 0.144 | Platelet activating factor beta antagonist | 0.144 0.04 CID_13878 | CID_13878 | |
| 0.12 | 0.035 | 0.121 | Alcohol dehydrogenase inhibitor | 0.121 0.034 CID_13878 | CID_13878 | |
| 0.095 | 0.011 | 0.095 | Cyclin B inhibitor | 0.095 0.011 CID_13878 | ||
| 0.105 | 0.021 | 0.11 | T cell inhibitor | 0.11 0.018 CID_13878 | CID_13878 | |
| 0.149 | 0.065 | 0.149 | Adenylate cyclase stimulant | 0.131 0.099 CID_13878 | ||
| 0.09 | 0.008 | 0.123 | Phosphoglycerate kinase inhibitor | 0.123 0.005 CID_13878 | CID_13878 | |
| 0.121 | 0.039 | 0.121 | GABA C receptor rho-1 antagonist | 0.111 0.049 CID_13878 | ||
| 0.11 | 0.03 | 0.11 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.107 0.032 CID_13878 | ||
| 0.118 | 0.041 | 0.138 | HIV-1 integrase (Overall Integration) inhibitor | 0.138 0.03 CID_13878 | CID_13878 | |
| 0.113 | 0.036 | 0.113 | Phosphodiesterase IV inhibitor | |||
| 0.081 | 0.004 | 0.081 | Adenosine A1 receptor agonist | 0.064 0.005 CID_13878 | ||
| 0.186 | 0.112 | 0.186 | Aldehyde oxidase inhibitor | |||
| 0.174 | 0.101 | 0.174 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.092 | 0.021 | 0.092 | DNA gyrase inhibitor | 0.065 0.043 CID_13878 | ||
| 0.162 | 0.092 | 0.162 | Succinate dehydrogenase inhibitor | |||
| 0.177 | 0.107 | 0.177 | Angiogenesis stimulant | 0.157 0.118 CID_13878 | ||
| 0.154 | 0.085 | 0.218 | Protein kinase (CK1) gamma 3 inhibitor | 0.218 0.038 CID_13878 | CID_13878 | |
| 0.16 | 0.091 | 0.16 | Amyloid beta precursor protein antagonist | |||
| 0.077 | 0.008 | 0.077 | Phosphodiesterase 7A inhibitor | 0.07 0.011 CID_13878 | ||
| 0.144 | 0.077 | 0.144 | MAP kinase 3 inhibitor | 0.143 0.079 CID_13878 | ||
| 0.13 | 0.063 | 0.13 | Epidermal growth factor receptor kinase inhibitor | 0.116 0.077 CID_13878 | ||
| 0.08 | 0.013 | 0.08 | Purinergic P2Y antagonist | 0.051 0.026 CID_13878 | ||
| 0.11 | 0.045 | 0.11 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.093 | 0.027 | 0.129 | Cyclin A2 inhibitor | 0.129 0.017 CID_13878 | CID_13878 | |
| 0.091 | 0.026 | 0.091 | CDK2/cyclin E inhibitor | 0.081 0.03 CID_13878 | ||
| 0.085 | 0.022 | 0.085 | Phosphodiesterase VII inhibitor | 0.078 0.027 CID_13878 | ||
| 0.135 | 0.072 | 0.136 | Cyclin-dependent kinase 7 inhibitor | 0.136 0.071 CID_13878 | CID_13878 | |
| 0.094 | 0.031 | 0.108 | CDK1/cyclin B1 inhibitor | 0.108 0.025 CID_13878 | CID_13878 | |
| 0.065 | 0.004 | 0.065 | Corticotropin releasing factor 1 receptor antagonist | 0.036 0.008 CID_13878 | ||
| 0.103 | 0.044 | 0.103 | Insulin growth factor antagonist | 0.088 0.057 CID_13878 | ||
| 0.079 | 0.023 | 0.079 | Acyl-CoA dehydrogenase inhibitor | 0.069 0.027 CID_13878 | ||
| 0.111 | 0.055 | 0.115 | MAP kinase 9 inhibitor | 0.115 0.052 CID_13878 | CID_13878 | |
| 0.099 | 0.043 | 0.099 | Insulin like growth factor 1 antagonist | 0.085 0.055 CID_13878 | ||
| 0.121 | 0.066 | 0.146 | Adenylate cyclase inhibitor | 0.146 0.048 CID_13878 | CID_13878 | |
| 0.069 | 0.015 | 0.069 | Carbonic anhydrase IV inhibitor | 0.047 0.027 CID_13878 | ||
| 0.083 | 0.03 | 0.114 | Cyclin A inhibitor | 0.114 0.019 CID_13878 | CID_13878 | |
| 0.091 | 0.039 | 0.091 | Caspase 7 inhibitor | |||
| 0.068 | 0.016 | 0.068 | Carbonic anhydrase VII inhibitor | 0.042 0.038 CID_13878 | ||
| 0.094 | 0.047 | 0.094 | Bcr-Abl kinase inhibitor | |||
| 0.063 | 0.017 | 0.063 | Potassium channel (Inward rectifier) activator | |||
| 0.125 | 0.081 | 0.155 | Protein-tyrosine kinase Lyn inhibitor | 0.155 0.063 CID_13878 | CID_13878 | |
| 0.081 | 0.036 | 0.087 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.087 0.026 CID_13878 | CID_13878 | |
| 0.089 | 0.044 | 0.089 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.06 | 0.016 | 0.06 | Potassium channel (ATP-sensitive) activator | |||
| 0.136 | 0.092 | 0.136 | Ca2+-transporting ATPase inhibitor | |||
| 0.071 | 0.027 | 0.071 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.077 | 0.034 | 0.077 | Purinergic P2 antagonist | |||
| 0.045 | 0.003 | 0.045 | Adenosine A2b receptor agonist | 0.038 0.003 CID_13878 | ||
| 0.075 | 0.034 | 0.075 | MAP kinase kinase 10 inhibitor | |||
| 0.103 | 0.062 | 0.103 | Adenylate kinase inhibitor | 0.097 0.073 CID_13878 | ||
| 0.068 | 0.027 | 0.09 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.09 0.017 CID_13878 | CID_13878 | |
| 0.085 | 0.044 | 0.085 | Porphobilinogen synthase inhibitor | |||
| 0.057 | 0.017 | 0.057 | CDK7/cyclin H inhibitor | 0.045 0.032 CID_13878 | ||
| 0.043 | 0.004 | 0.058 | Adenosine A2 receptor agonist | 0.058 0.003 CID_13878 | CID_13878 | |
| 0.065 | 0.026 | 0.065 | Glucosylceramidase inhibitor | |||
| 0.055 | 0.018 | 0.073 | Histamine H2 receptor agonist | 0.073 0.009 CID_13878 | CID_13878 | |
| 0.063 | 0.027 | 0.063 | MAP kinase kinase 9 inhibitor | |||
| 0.071 | 0.035 | 0.071 | 5 Hydroxytryptamine 3 agonist | |||
| 0.06 | 0.024 | 0.06 | Immunoglobulin Fc receptor antagonist | 0.06 0.024 CID_13878 | ||
| 0.039 | 0.004 | 0.043 | Adenosine A2a receptor agonist | 0.043 0.003 CID_13878 | CID_13878 | |
| 0.039 | 0.004 | 0.039 | Purinergic P2Y1 antagonist | 0.027 0.005 CID_13878 | ||
| 0.092 | 0.058 | 0.126 | Glutamate release inhibitor | 0.126 0.018 CID_13878 | CID_13878 | |
| 0.039 | 0.005 | 0.083 | Histamine H4 receptor agonist | 0.083 0.003 CID_13878 | CID_13878 | |
| 0.05 | 0.016 | 0.05 | Potassium channel KCNQ activator | |||
| 0.05 | 0.016 | 0.05 | Delayed rectifier potassium channel activator | |||
| 0.054 | 0.021 | 0.054 | Potassium channel small-conductance Ca-activated blocker | 0.043 0.035 CID_13878 | ||
| 0.125 | 0.093 | 0.125 | Cyclooxygenase inhibitor | |||
| 0.074 | 0.043 | 0.114 | I kappa B kinase 1 inhibitor | 0.114 0.017 CID_13878 | CID_13878 | |
| 0.049 | 0.02 | 0.078 | Dihydrofolate reductase inhibitor | 0.078 0.005 CID_13878 | CID_13878 | |
| 0.062 | 0.034 | 0.065 | Cyclin A1 inhibitor | 0.065 0.028 CID_13878 | CID_13878 | |
| 0.134 | 0.106 | 0.204 | Heat shock protein 90 alpha antagonist | 0.204 0.047 CID_13878 | CID_13878 | |
| 0.138 | 0.111 | 0.18 | LIM domain kinase 1 inhibitor | 0.18 0.073 CID_13878 | CID_13878 | |
| 0.182 | 0.155 | 0.182 | Neuropeptide Y2 antagonist | |||
| 0.077 | 0.05 | 0.077 | Vanilloid antagonist | |||
| 0.078 | 0.052 | 0.078 | Estrogen receptor alpha antagonist | |||
| 0.036 | 0.011 | 0.036 | DNA topoisomerase IV inhibitor | 0.029 0.024 CID_13878 | ||
| 0.064 | 0.039 | 0.064 | Carbamoyl phosphate synthetase inhibitor | 0.058 0.045 CID_13878 | ||
| 0.038 | 0.014 | 0.038 | Protein kinase (CK2) beta inhibitor | |||
| 0.111 | 0.089 | 0.111 | Cathepsin H inhibitor | |||
| 0.106 | 0.084 | 0.106 | Estrogen antagonist | |||
| 0.036 | 0.014 | 0.036 | Cyclin E2 inhibitor | 0.03 0.019 CID_13878 | ||
| 0.084 | 0.062 | 0.098 | Histamine N-methyltransferase inhibitor | 0.098 0.048 CID_13878 | CID_13878 | |
| 0.046 | 0.025 | 0.046 | Histamine H1 receptor agonist | |||
| 0.067 | 0.047 | 0.067 | Vanilloid 1 antagonist | |||
| 0.067 | 0.047 | 0.067 | Potassium channel (ATP-sensitive) blocker | 0.063 0.053 CID_13878 | ||
| 0.188 | 0.168 | 0.188 | Gastrin inhibitor | |||
| 0.049 | 0.029 | 0.049 | CC chemokine 4 receptor antagonist | |||
| 0.066 | 0.047 | 0.066 | p38 MAP kinase inhibitor | |||
| 0.107 | 0.088 | 0.107 | Transcription factor STAT6 inhibitor | |||
| 0.091 | 0.072 | 0.091 | UDP-glucose 4-epimerase inhibitor | |||
| 0.067 | 0.049 | 0.108 | Phenylalanine 4-hydroxylase inhibitor | 0.108 0.022 CID_13878 | CID_13878 | |
| 0.049 | 0.033 | 0.073 | Histamine H4 receptor antagonist | 0.073 0.011 CID_13878 | CID_13878 | |
| 0.031 | 0.016 | 0.031 | Purinergic P2Y15 antagonist | 0.03 0.018 CID_13878 | ||
| 0.049 | 0.035 | 0.049 | Potassium channel (Inward rectifier) blocker | |||
| 0.035 | 0.022 | 0.035 | Adenosine uptake inhibitor | |||
| 0.114 | 0.101 | 0.222 | CDC-like kinase 1 inhibitor | 0.222 0.026 CID_13878 | CID_13878 | |
| 0.107 | 0.094 | 0.107 | Acetylcholinesterase inhibitor | |||
| 0.04 | 0.027 | 0.066 | Dihydropteroate synthase inhibitor | 0.066 0.009 CID_13878 | CID_13878 | |
| 0.047 | 0.034 | 0.047 | Benzodiazepine antagonist | |||
| 0.191 | 0.18 | 0.223 | Angiogenesis inhibitor | 0.223 0.145 CID_13878 | CID_13878 | |
| 0.058 | 0.046 | 0.067 | Cyclin B1 inhibitor | 0.067 0.035 CID_13878 | CID_13878 | |
| 0.019 | 0.008 | 0.02 | Prokineticin receptor 1 antagonist | 0.02 0.007 CID_13878 | CID_13878 | |
| 0.051 | 0.042 | 0.051 | Alpha-mannosidase inhibitor | |||
| 0.079 | 0.07 | 0.079 | Estrogen-related receptor beta agonist | |||
| 0.067 | 0.058 | 0.067 | Aminopeptidase I inhibitor | |||
| 0.052 | 0.044 | 0.059 | Cyclin B2 inhibitor | 0.059 0.034 CID_13878 | CID_13878 | |
| 0.237 | 0.229 | 0.237 | Apoptosis agonist | |||
| 0.05 | 0.042 | 0.05 | Ribonucleotide reductase inhibitor | |||
| 0.056 | 0.049 | 0.056 | Potassium channel (Ca-activated) blocker | |||
| 0.104 | 0.099 | 0.104 | Cyclooxygenase 2 inhibitor | |||
| 0.048 | 0.043 | 0.048 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.08 | 0.076 | 0.08 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.082 | 0.079 | 0.082 | Aminopeptidase B inhibitor | |||
| 0.04 | 0.038 | 0.04 | Geranyltranstransferase inhibitor | |||
| 0.014 | 0.013 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.011 CID_13878 | CID_13878 | |
| 0.015 | 0.015 | 0.017 | CDK2/cyclin A3 inhibitor | 0.017 0.01 CID_13878 | CID_13878 | |
| 0.079 | 0.078 | 0.079 | Triose-phosphate isomerase inhibitor | |||
| 0.065 | 0.065 | 0.068 | Glutamate dehydrogenase inhibitor | 0.068 0.06 CID_13878 | CID_13878 | |
| 0.033 | 0.033 | 0.034 | Diamine oxidase inhibitor | 0.034 0.032 CID_13878 | CID_13878 | |
| 0.075 | 0.076 | 0.106 | Myeloperoxidase inhibitor | 0.106 0.029 CID_13878 | CID_13878 | |
| 0.048 | 0.05 | 0.052 | Argininosuccinate synthase inhibitor | 0.052 0.045 CID_13878 | CID_13878 | |
| 0.033 | 0.035 | 0.044 | Tryptophan 5 hydroxylase inhibitor | 0.044 0.009 CID_13878 | CID_13878 | |
| 0.015 | 0.018 | 0.023 | Cyclin T1 inhibitor | 0.023 0.009 CID_13878 | CID_13878 | |
| 0.096 | 0.101 | 0.115 | RET inhibitor | 0.115 0.082 CID_13878 | CID_13878 | |
| 0.042 | 0.048 | 0.045 | Ornithine carbamoyltransferase inhibitor | 0.045 0.044 CID_13878 | CID_13878 | |
| 0.038 | 0.045 | 0.059 | Thymidylate synthase inhibitor | 0.059 0.018 CID_13878 | CID_13878 | |
| 0.037 | 0.045 | 0.059 | Antimetabolite | 0.059 0.026 CID_13878 | CID_13878 | |
| 0.065 | 0.074 | 0.115 | TIE-2 antagonist | 0.115 0.032 CID_13878 | CID_13878 | |
| 0.085 | 0.094 | 0.099 | Carbonic anhydrase XV inhibitor | 0.099 0.068 CID_13878 | CID_13878 | |
| 0.055 | 0.066 | 0.087 | CDC7 inhibitor | 0.087 0.031 CID_13878 | CID_13878 | |
| 0.036 | 0.046 | 0.05 | Adenosine deaminase inhibitor | 0.05 0.03 CID_13878 | CID_13878 | |
| 0.018 | 0.029 | 0.03 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.03 0.018 CID_13878 | CID_13878 | |
| 0.065 | 0.076 | 0.115 | TIE antagonist | 0.115 0.033 CID_13878 | CID_13878 | |
| 0.018 | 0.031 | 0.021 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 CID_13878 | CID_13878 | |
| 0.105 | 0.118 | 0.266 | Protein kinase (CK1) gamma 1 inhibitor | 0.266 0.026 CID_13878 | CID_13878 | |
| 0.069 | 0.087 | 0.083 | MAP kinase kinase 7 inhibitor | 0.083 0.038 CID_13878 | CID_13878 | |
| 0.05 | 0.07 | 0.063 | Fibroblast growth factor 2 antagonist | 0.063 0.049 CID_13878 | CID_13878 | |
| 0.061 | 0.081 | 0.069 | Fibroblast growth factor 3 antagonist | 0.069 0.066 CID_13878 | CID_13878 | |
| 0.013 | 0.041 | 0.023 | Tryptophan hydroxylase 1 inhibitor | 0.023 0.005 CID_13878 | CID_13878 | |
| 0.091 | 0.12 | 0.104 | Interleukin 8 antagonist | 0.104 0.087 CID_13878 | CID_13878 | |
| 0.073 | 0.106 | 0.096 | Cyclin-dependent kinase 9 inhibitor | 0.096 0.067 CID_13878 | CID_13878 | |
| 0.116 | 0.151 | 0.136 | DNA methyltransferase I inhibitor | 0.136 0.121 CID_13878 | CID_13878 | |
| 0.121 | 0.159 | 0.162 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.162 0.102 CID_13878 | CID_13878 | |
| 0.079 | 0.118 | 0.197 | Protein kinase (CK1) gamma 2 inhibitor | 0.197 0.033 CID_13878 | CID_13878 | |
| 0.088 | 0.148 | 0.131 | Protein kinase C nu inhibitor | 0.131 0.082 CID_13878 | CID_13878 | |
| 0.085 | 0.146 | 0.2 | Protein kinase (CK1) gamma inhibitor | 0.2 0.044 CID_13878 | CID_13878 | |
| 0.04 | 0.112 | 0.056 | Heat shock protein 90 beta antagonist | 0.056 0.047 CID_13878 | CID_13878 | |
| 0.06 | 0.15 | 0.08 | mTOR complex 2 inhibitor | 0.08 0.069 CID_13878 | CID_13878 | |
| 0.071 | 0.167 | 0.223 | Folate antagonist | 0.223 0.007 CID_13878 | CID_13878 | |
| 0.143 | 0.252 | 0.195 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.195 0.164 CID_13878 | CID_13878 | |
| 0.048 | 0.167 | 0.122 | Protein kinase (CK1) delta inhibitor | 0.122 0.072 CID_13878 | CID_13878 | |
| 0.074 | 0.208 | 0.175 | Clk dual-specificity kinase inhibitor | 0.175 0.095 CID_13878 | CID_13878 | |
| 0.047 | 0.197 | 0.125 | Protein kinase (CK1) inhibitor | 0.125 0.087 CID_13878 | CID_13878 | |
| 0.007 | 0.166 | 0.021 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.021 0.006 CID_13878 | CID_13878 | |
| 0.04 | 0.289 | 0.133 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.133 0.102 CID_13878 | CID_13878 | |
| 0.034 | 0.436 | 0.097 | mTOR complex 1 inhibitor | 0.097 0.069 CID_13878 | CID_13878 | |
| 0.035 | 0.518 | 0.153 | Interleukin 4 antagonist | 0.153 0.047 CID_13878 | CID_13878 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |